Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy. 1996

C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
AMB-BIO, ENEA, CR-Casaccia, Rome, Italy.

We have applied the cytokinesis-block micronucleus assay to peripheral blood lymphocytes of patients undergoing radiotherapy in pelvic and pulmonary sites, in order to evaluate the individual cytogenetic response. Our cytogenetic data correlated with the equivalent whole-body dose are homogeneous and compare well with the data presented by other authors. We have used an exponential mathematical formula to calculate the attenuation of the cytogenetic effect with time. The k coefficient (cytogenetic recovery factor) in the formula expresses the degree of attenuation. In lymphocytes from patients after radiotherapy, the trend of the micronucleus frequency observed after 2 Gy of in vitro X-irradiation demonstrates that the cytogenetic effect obtained in vitro is added to that obtained in vivo. The k coefficient is inversely proportional to the micronucleus frequency observed after 2 Gy in vitro. The micronucleus assay and the cytogenetic recovery factor are proposed as suitable diagnostic tools for application in the field of radiotherapy.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015162 Micronucleus Tests Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei (MICRONUCLEI, CHROMOSOME-DEFECTIVE) in cells which have been exposed to genotoxic agents or IONIZING RADIATION. Micronucleus Assays,Assay, Micronucleus,Assays, Micronucleus,Micronucleus Assay,Micronucleus Test,Test, Micronucleus,Tests, Micronucleus

Related Publications

C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
February 1990, International journal of radiation biology,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
January 2023, Methods in molecular biology (Clifton, N.J.),
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
August 1994, Mutation research,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
March 2002, Mutagenesis,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
January 1999, Neoplasma,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
January 2003, Radiation protection dosimetry,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
January 1988, IARC scientific publications,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
January 1990, Teratogenesis, carcinogenesis, and mutagenesis,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
October 1994, Cytometry,
C Catena, and D Conti, and P Parasacchi, and P Marenco, and B Bortolato, and M Botturi, and M Leoni, and M Portaluri, and P G Paleani-Vettori, and E Righi
August 1997, Mutation research,
Copied contents to your clipboard!